Eargo 5 vs Otofonix Encore

The Eargo 5 is a premium-priced OTC hearing aid ($1,450) that earns a B grade with a SoundScore of 3.6/5 in our lab testing. This invisible-in-ear device offers a discreet rechargeable design, though its acoustic performance shows notable strengths and weaknesses compared to alternatives in its price range. In our testing, the Eargo 5 demonstrates solid speech-in-quiet performance at 3.5/5, scoring 0.75 points above the OTC category average. Own-voice comfort also measures above average, which may appeal to users sensitive to occlusion effects. However, speech-in-noise performance is low at 1.4/5, and music streaming scores 0.0/5—significantly below the category average of 1.92/5. Users who prioritize phone streaming or frequently encounter noisy environments should consider these limitations. Feedback handling is strong in absolute terms at 4.2/5, though slightly below the category average of 4.54/5. The device uses closed sleeves for ear coupling in both initial and tuned configurations, with minimal score improvement from tuning (3.6 to 3.7/5). At this price point, competitors like the Lucid Tala (4.63/5) and Audicus Omni 2 (4.61/5) offer substantially higher overall sound performance. Budget-conscious shoppers may also find similar or better sound quality from lower-priced options like the Sony CRE-C10. The Eargo 5 may suit users who prioritize invisible cosmetics and quiet-environment listening over streaming and noise performance.

The Otofonix Encore is a behind-the-ear prescription hearing aid priced at $295, placing it in the budget tier of the prescription category. In our lab testing, it earned a C grade with a SoundScore of 2.7/5, ranking 35th out of 36 prescription hearing aids tested. Sound performance presents significant challenges across most metrics. Speech clarity scores are low in both quiet (1.0/5) and noisy environments (1.0/5), falling 2.32 and 0.96 points below category averages respectively. Music streaming capability is essentially absent at 0.0/5, and own-voice comfort is notably limited at 0.1/5 in the tuned configuration—2.65 points below the category average. The one bright spot is feedback handling, which scores an excellent 4.7/5. While this falls just 0.01 points below the category average, it represents strong absolute performance that should minimize whistling issues during daily use. This device runs on disposable batteries. At this price point, shoppers should be aware that the RxEars Rxi offers substantially better sound performance (4.09/5) in the same price range. The Otofonix Encore may suit budget-conscious consumers who prioritize feedback stability over speech clarity and streaming features, but our testing suggests most users would benefit from considering higher-performing alternatives within this price tier.